MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity.

[1]  Matthew D. Dun,et al.  Salmeterol attenuates chemotactic responses in rhinovirus-induced exacerbation of allergic airways disease by modulating protein phosphatase 2A. , 2014, The Journal of allergy and clinical immunology.

[2]  S. Johnston,et al.  The emerging role of microRNAs in regulating immune and inflammatory responses in the lung , 2013, Immunological reviews.

[3]  S. Johnston,et al.  The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity , 2013, Nature Medicine.

[4]  Y. Peterson,et al.  Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis , 2012, EMBO molecular medicine.

[5]  P. Foster,et al.  Targeting translational control as a novel way to treat inflammatory disease: the emerging role of microRNAs. , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[6]  F. Ceciliani,et al.  Escherichia coli lipopolysaccharides and Staphylococcus aureus enterotoxin B differentially modulate inflammatory microRNAs in bovine monocytes. , 2012, Veterinary journal.

[7]  Rakesh K. Kumar,et al.  Emerging roles of pulmonary macrophages in driving the development of severe asthma , 2012, Journal of leukocyte biology.

[8]  Pietro Invernizzi,et al.  MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response. , 2012, Autoimmunity reviews.

[9]  Xu Gao,et al.  A microRNA “target pools” remains mysterious , 2012, Journal of cellular biochemistry.

[10]  J. Pekow,et al.  MicroRNAs in inflammatory bowel disease , 2012, Inflammatory bowel diseases.

[11]  P. Barnes,et al.  Defects of Protein Phosphatase 2A Causes Corticosteroid Insensitivity in Severe Asthma , 2011, PloS one.

[12]  Xiaoman Li,et al.  Transcriptional regulation of co-expressed microRNA target genes. , 2011, Genomics.

[13]  F. Slack,et al.  MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy , 2011, Nature Reviews Cancer.

[14]  M. Ascano,et al.  New insights in the mechanism of microRNA-mediated target repression , 2011, Nature Structural &Molecular Biology.

[15]  Ankur Kulshreshtha,et al.  Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation. , 2011, The Journal of allergy and clinical immunology.

[16]  P. Greengard,et al.  Protein Kinase C-Dependent Dephosphorylation of Tyrosine Hydroxylase Requires the B56δ Heterotrimeric Form of Protein Phosphatase 2A , 2011, PloS one.

[17]  A. Khakoo,et al.  MicroRNA-9 is an activation-induced regulator of PDGFR-beta expression in cardiomyocytes. , 2011, Journal of molecular and cellular cardiology.

[18]  P. Foster,et al.  Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. , 2011, The Journal of allergy and clinical immunology.

[19]  Rakesh K. Kumar,et al.  Altered expression of microRNA in the airway wall in chronic asthma: miR-126 as a potential therapeutic target , 2011, BMC pulmonary medicine.

[20]  I. Landrieu,et al.  Mice lacking phosphatase PP2A subunit PR61/B’δ (Ppp2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3β , 2011, Proceedings of the National Academy of Sciences.

[21]  L. O’Neill,et al.  MicroRNAs: the fine-tuners of Toll-like receptor signalling , 2011, Nature Reviews Immunology.

[22]  D. Wink,et al.  Targeting SET/I2PP2A Oncoprotein Functions as a Multi-pathway Strategy for Cancer Therapy , 2010, Oncogene.

[23]  I. Oglesby,et al.  MicroRNAs in inflammatory lung disease - master regulators or target practice? , 2010, Respiratory research.

[24]  Rakesh K. Kumar,et al.  IL-27/IFN-γ Induce MyD88-Dependent Steroid-Resistant Airway Hyperresponsiveness by Inhibiting Glucocorticoid Signaling in Macrophages , 2010, The Journal of Immunology.

[25]  Michael A Lopez,et al.  Mechanical Stretch Up-regulates MicroRNA-26a and Induces Human Airway Smooth Muscle Hypertrophy by Suppressing Glycogen Synthase Kinase-3β* , 2010, The Journal of Biological Chemistry.

[26]  G. Calin,et al.  MYC-microRNA-9-metastasis connection in breast cancer , 2010, Cell Research.

[27]  Jung-Hyuck Ahn,et al.  Phosphorylation on the PPP2R5D B regulatory subunit modulates the biochemical properties of protein phosphatase 2A. , 2010, BMB reports.

[28]  P. Foster,et al.  Interferon‐γ and pulmonary macrophages contribute to the mechanisms underlying prolonged airway hyperresponsiveness , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[29]  N. McCarthy.  Cancer: Small losses, big gains with microRNAs , 2010, Nature Reviews Genetics.

[30]  Min Liu,et al.  Regulation of the transcription factor NF-κB1 by microRNA-9 in human gastric adenocarcinoma , 2010, Molecular Cancer.

[31]  S. Phipps,et al.  Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease , 2009, Proceedings of the National Academy of Sciences.

[32]  S. Phipps,et al.  Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis. , 2009, Pharmacology & therapeutics.

[33]  J. Cidlowski,et al.  Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease , 2009, IUBMB life.

[34]  I. Adcock,et al.  Glucocorticoid resistance in inflammatory diseases , 2009, The Lancet.

[35]  P. Gibson.  Tackling asthma phenotypes in community studies , 2009, Thorax.

[36]  Rakesh K. Kumar,et al.  Pathogenesis of Steroid-Resistant Airway Hyperresponsiveness: Interaction between IFN-γ and TLR4/MyD88 Pathways 1 , 2009, The Journal of Immunology.

[37]  A. Mantovani,et al.  Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals , 2009, Proceedings of the National Academy of Sciences.

[38]  J. Douglas,et al.  Difficult to treat asthma in adults , 2009, BMJ : British Medical Journal.

[39]  S. Armstrong,et al.  miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221. , 2008, Blood.

[40]  S. Aizawa,et al.  MicroRNA-9 Modulates Cajal–Retzius Cell Differentiation by Suppressing Foxg1 Expression in Mouse Medial Pallium , 2008, The Journal of Neuroscience.

[41]  G. Anderson,et al.  Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease , 2008, The Lancet.

[42]  I. Adcock,et al.  Molecular mechanisms of corticosteroid resistance. , 2008, Chest.

[43]  Claudio N. Cavasotto,et al.  Glucocorticoid receptor phosphorylation differentially affects target gene expression. , 2008, Molecular endocrinology.

[44]  C. Stigloher,et al.  MicroRNA-9 directs late organizer activity of the midbrain-hindbrain boundary , 2008, Nature Neuroscience.

[45]  B. McEwen,et al.  Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNA‐mediated down‐regulation of the glucocorticoid receptor , 2008, The European journal of neuroscience.

[46]  H. Lodish,et al.  Micromanagement of the immune system by microRNAs , 2008, Nature Reviews Immunology.

[47]  P. Wark,et al.  Understanding the mechanisms of viral induced asthma: New therapeutic directions , 2008, Pharmacology & Therapeutics.

[48]  J. Douwes,et al.  Innate immune activation in neutrophilic asthma and bronchiectasis , 2007, Thorax.

[49]  Angus C Nairn,et al.  Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56δ subunit , 2007, Proceedings of the National Academy of Sciences.

[50]  Yigong Shi,et al.  Structure of the Protein Phosphatase 2A Holoenzyme , 2006, Cell.

[51]  M. Idzko,et al.  Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. , 2006, The Journal of clinical investigation.

[52]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[53]  A. Abderrahmani,et al.  MicroRNA-9 Controls the Expression of Granuphilin/Slp4 and the Secretory Response of Insulin-producing Cells* , 2006, Journal of Biological Chemistry.

[54]  I. Adcock,et al.  Update on glucocorticoid action and resistance. , 2006, The Journal of allergy and clinical immunology.

[55]  R. Scott,et al.  Inflammatory subtypes in asthma: Assessment and identification using induced sputum , 2006, Respirology.

[56]  Frédéric Blanchard,et al.  Transformation of human bronchial epithelial cells alters responsiveness to inflammatory cytokines , 2005, BMC Cancer.

[57]  J. Gulcher,et al.  Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[58]  R. Scott,et al.  Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. , 2005, American journal of respiratory and critical care medicine.

[59]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[60]  D. Kemeny,et al.  Inhibition of Th1- and Th2-Mediated Airway Inflammation by the Sphingosine 1-Phosphate Receptor Agonist FTY720 , 2003, The Journal of Immunology.

[61]  L. Lim,et al.  An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans , 2001, Science.

[62]  T. Shanley,et al.  The Serine/Threonine Phosphatase, PP2A: Endogenous Regulator of Inflammatory Cell Signaling1 , 2001, The Journal of Immunology.

[63]  S. Wenzel,et al.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.

[64]  K. Nagata,et al.  Functional domains of template-activating factor-I as a protein phosphatase 2A inhibitor. , 1999, Biochemical and biophysical research communications.

[65]  Y. Ip,et al.  Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development. , 1998, Current opinion in cell biology.

[66]  S. Logan,et al.  Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[67]  D. Postma,et al.  Elevated serum interferon-gamma in atopic asthma correlates with increased airways responsiveness and circadian peak expiratory flow variation. , 1998, The European respiratory journal.

[68]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[69]  M. Garabedian,et al.  Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors. , 1991, Molecular endocrinology.